These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 22743997)

  • 1. Unveiling an exceptional zymogen: the single-chain form of tPA is a selective activator of NMDA receptor-dependent signaling and neurotoxicity.
    Parcq J; Bertrand T; Montagne A; Baron AF; Macrez R; Billard JM; Briens A; Hommet Y; Wu J; Yepes M; Lijnen HR; Dutar P; Anglés-Cano E; Vivien D
    Cell Death Differ; 2012 Dec; 19(12):1983-91. PubMed ID: 22743997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors.
    Martin AM; Kuhlmann C; Trossbach S; Jaeger S; Waldron E; Roebroek A; Luhmann HJ; Laatsch A; Weggen S; Lessmann V; Pietrzik CU
    J Biol Chem; 2008 May; 283(18):12004-13. PubMed ID: 18321860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Conformations of tissue plasminogen activator (tPA) orchestrate neuronal survival by a crosstalk between EGFR and NMDAR.
    Bertrand T; Lesept F; Chevilley A; Lenoir S; Aimable M; Briens A; Hommet Y; Bardou I; Parcq J; Vivien D
    Cell Death Dis; 2015 Oct; 6(10):e1924. PubMed ID: 26469972
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NR2D-containing NMDA receptors mediate tissue plasminogen activator-promoted neuronal excitotoxicity.
    Baron A; Montagne A; Cassé F; Launay S; Maubert E; Ali C; Vivien D
    Cell Death Differ; 2010 May; 17(5):860-71. PubMed ID: 19911010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tissue-type plasminogen activator controls neuronal death by raising surface dynamics of extrasynaptic NMDA receptors.
    Lesept F; Chevilley A; Jezequel J; Ladépêche L; Macrez R; Aimable M; Lenoir S; Bertrand T; Rubrecht L; Galea P; Lebouvier L; Petersen KU; Hommet Y; Maubert E; Ali C; Groc L; Vivien D
    Cell Death Dis; 2016 Nov; 7(11):e2466. PubMed ID: 27831563
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cleavage of the NR2B subunit amino terminus of N-methyl-D-aspartate (NMDA) receptor by tissue plasminogen activator: identification of the cleavage site and characterization of ifenprodil and glycine affinities on truncated NMDA receptor.
    Ng KS; Leung HW; Wong PT; Low CM
    J Biol Chem; 2012 Jul; 287(30):25520-9. PubMed ID: 22610100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tissue-type plasminogen activator requires a co-receptor to enhance NMDA receptor function.
    Samson AL; Nevin ST; Croucher D; Niego B; Daniel PB; Weiss TW; Moreno E; Monard D; Lawrence DA; Medcalf RL
    J Neurochem; 2008 Nov; 107(4):1091-101. PubMed ID: 18796005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tissue-type plasminogen activator protects neurons from excitotoxin-induced cell death via activation of the ERK1/2-CREB-ATF3 signaling pathway.
    Wu F; Echeverry R; Wu J; An J; Haile WB; Cooper DS; Catano M; Yepes M
    Mol Cell Neurosci; 2013 Jan; 52():9-19. PubMed ID: 23063501
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue plasminogen activator mediates amyloid-induced neurotoxicity via Erk1/2 activation.
    Medina MG; Ledesma MD; Domínguez JE; Medina M; Zafra D; Alameda F; Dotti CG; Navarro P
    EMBO J; 2005 May; 24(9):1706-16. PubMed ID: 15861134
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HMGB-1 promotes fibrinolysis and reduces neurotoxicity mediated by tissue plasminogen activator.
    Roussel BD; Mysiorek C; Rouhiainen A; Jullienne A; Parcq J; Hommet Y; Culot M; Berezowski V; Cecchelli R; Rauvala H; Vivien D; Ali C
    J Cell Sci; 2011 Jun; 124(Pt 12):2070-6. PubMed ID: 21610098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vampire bat salivary plasminogen activator (desmoteplase): a unique fibrinolytic enzyme that does not promote neurodegeneration.
    Liberatore GT; Samson A; Bladin C; Schleuning WD; Medcalf RL
    Stroke; 2003 Feb; 34(2):537-43. PubMed ID: 12574572
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Switching of N-methyl-D-aspartate (NMDA) receptor-favorite intracellular signal pathways from ERK1/2 protein to p38 mitogen-activated protein kinase leads to developmental changes in NMDA neurotoxicity.
    Xiao L; Hu C; Feng C; Chen Y
    J Biol Chem; 2011 Jun; 286(23):20175-93. PubMed ID: 21474451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two-Chains Tissue Plasminogen Activator Unifies Met and NMDA Receptor Signalling to Control Neuronal Survival.
    Hedou E; Douceau S; Chevilley A; Varangot A; Thiebaut AM; Triniac H; Bardou I; Ali C; Maillasson M; Crepaldi T; Comoglio P; Lemarchand E; Agin V; Roussel BD; Vivien D
    Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.
    Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E
    J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmin potentiates synaptic N-methyl-D-aspartate receptor function in hippocampal neurons through activation of protease-activated receptor-1.
    Mannaioni G; Orr AG; Hamill CE; Yuan H; Pedone KH; McCoy KL; Berlinguer Palmini R; Junge CE; Lee CJ; Yepes M; Hepler JR; Traynelis SF
    J Biol Chem; 2008 Jul; 283(29):20600-11. PubMed ID: 18474593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tissue plasminogen activator protects hippocampal neurons from oxygen-glucose deprivation injury.
    Flavin MP; Zhao G
    J Neurosci Res; 2001 Mar; 63(5):388-94. PubMed ID: 11223913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator mediates microglial activation via its finger domain through annexin II.
    Siao CJ; Tsirka SE
    J Neurosci; 2002 May; 22(9):3352-8. PubMed ID: 11978811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 2,7-Bis-(4-amidinobenzylidene)-cycloheptan-1-one dihydrochloride, tPA stop, prevents tPA-enhanced excitotoxicity both in vitro and in vivo.
    Liot G; Benchenane K; Léveillé F; López-Atalaya JP; Fernández-Monreal M; Ruocco A; Mackenzie ET; Buisson A; Ali C; Vivien D
    J Cereb Blood Flow Metab; 2004 Oct; 24(10):1153-9. PubMed ID: 15529015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Toward safer thrombolytic agents in stroke: molecular requirements for NMDA receptor-mediated neurotoxicity.
    Lopez-Atalaya JP; Roussel BD; Levrat D; Parcq J; Nicole O; Hommet Y; Benchenane K; Castel H; Leprince J; To Van D; Bureau R; Rault S; Vaudry H; Petersen KU; Santos JS; Ali C; Vivien D
    J Cereb Blood Flow Metab; 2008 Jun; 28(6):1212-21. PubMed ID: 18334994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distant Space Processing is Controlled by tPA-dependent NMDA Receptor Signaling in the Entorhinal Cortex.
    Hébert M; Anfray A; Chevilley A; Martinez de Lizarrondo S; Quenault A; Louessard M; Roussel BD; Obiang P; Save E; Orset C; Maubert E; Vivien D; Agin V
    Cereb Cortex; 2017 Oct; 27(10):4783-4796. PubMed ID: 27613436
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.